Nutritional Intervention to Reduce Alcohol Consumption
NCT06787235 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2025-09-24
Summary
To test whether the implementation of a modified ketogenic diet (KD) is efficient in reducing outcome measures in relation to alcohol consumption in patients with alcohol use disorder (AUD).
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Modified ketogenic diet
The modified Atkins KD is defined as \<20g carbohydrate per day with freely allowed protein consumption. Recommended protein and fat intake will be calculated for each participant based on their energy needs.
- OTHER
-
Individual nutritional consultation
The nutritional consultation will be provided by a dietician to improve individual health
Sponsors & Collaborators
-
University of Bern
lead OTHER
Principal Investigators
-
Philippe Pfeifer · University of Bern
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-01
- Primary Completion
- 2026-02-28
- Completion
- 2026-04-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder
NCT06559995 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Metabolism in the Human Brain Following Consumption of a Keto-ester in Alcohol Use Disorder (AUD) With Proton Magnetic Resonance Spectroscopic Imaging (MRSI)
NCT05937893 ·Status: COMPLETED ·Phase: NA
-
Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder
NCT05015881 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
Ketamine for Reduction of Alcoholic Relapse
NCT02649231 ·Status: COMPLETED ·Phase: PHASE2
-
ACT_for Alcohol Use Disorder and Depression
NCT06620276 ·Status: RECRUITING ·Phase: NA
-
Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders
NCT02968537 ·Status: COMPLETED ·Phase: NA
-
Inpatient Alcohol Detox & Psychotherapy
NCT03988478 ·Status: COMPLETED ·Phase: NA
-
Reducing Alcohol Use in Depressed Patients
NCT00183079 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder
NCT06969937 ·Status: RECRUITING ·Phase: PHASE2
-
PT150 Drug for Use in Alcohol Use Disorder
NCT06712602 ·Status: RECRUITING ·Phase: PHASE1
-
Development of a Selective ALDH2 Inhibitor to Treat AUD
NCT04311294 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effects of Cannabidiol in Alcohol Use Disorder
NCT03252756 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking
NCT04084860 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent Patients
NCT00758277 ·Status: COMPLETED ·Phase: PHASE3
-
Cerebellar Involvement in Alcohol Use Disorder (AUD)
NCT05732207 ·Status: RECRUITING ·Phase: NA
-
Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)
NCT05677321 ·Status: RECRUITING
-
Individually Adapted Therapy of Alcoholism
NCT00317031 ·Status: COMPLETED ·Phase: PHASE4
-
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
NCT02885311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Medication and Counseling for Controlled Drinking
NCT01115894 ·Status: UNKNOWN ·Phase: PHASE3
-
Outpatient Psychotherapeutic Treatment for Alcohol Dependent Individuals With Comorbid Psychiatric Disorders
NCT02141789 ·Status: COMPLETED ·Phase: NA
-
Psychosocial Intervention For Domiciliary Alcohol Detoxification
NCT05563740 ·Status: COMPLETED ·Phase: NA
-
Medication Development in Alcoholism: Acamprosate Versus Naltrexone
NCT00656630 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT04931095 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Levetiracetam on Alcohol Dependent Subjects
NCT00325182 ·Status: COMPLETED ·Phase: PHASE4
-
Intranasal Oxytocin for the Treatment of Alcohol Use Disorder
NCT03878316 ·Status: COMPLETED ·Phase: PHASE2